Home＜ Investor Relations

Investor Relations

Company Profile Corporate Governance

Information Disclosure

Announcements and Circulars Financial Reports and ESG Reports The Listed Files

Presentations & Webcasts Investor Relations Query

DISCLOSEABLE TRANSACTION IN RELATION TO CONSTRUCTION AGREEMENT FOR THE GLOBAL RESEARCH AND DEVELOPMENT CENTRE

Next Day Disclosure Returns

Terms of Reference for the Strategy and ESG Committee

(1) GRANT OF AWARD SHARES UNDER RESTRICTED SHARE AWARD SCHEME (2) ISSUE OF NEW SHARES UNDER GENERAL MANDATE (3) AMENDMENT TO SCHEME RULES

CONTINUING CONNECTED TRANSACTIONS IN RELATION TO TECHNICAL SERVICE AGREEMENT AND BUSINESS DEVELOPMENT SERVICE AGREEMENT

VOLUNTARY ANNOUNCEMENT - ENTERING INTO OF AN EXCLUSIVE PROMOTION SERVICE AGREEMENT WITH A WHOLLY-OWNED SUBSIDIARY OF JIMIN KEXIN PHARMACEUTICAL IN RESPECT OF PUSINTIN (BEVACIZUMAB INJECTION, PUSINTIN) FOR THE MAINLAND CHINA MARKET

CONNECTED TRANSACTION IN RELATION TO DISPOSAL OF LISTED SECURITIES

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021

INSIDE INFORMATION ANNOUNCEMENT - MARKETING APPROVAL FOR PUSINTIN (TAB008, BEVACIZUMAB INJECTION, PUSINTIN) OBTAINED FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION